| Not Yet Recruiting | Development of a Mindfulness-Based Smartphone Application for BMT Caregivers Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients | N/A | 2026-08-01 |
| Not Yet Recruiting | Modifying Diet to Improve Gut Microbiome Obesity | N/A | 2026-07-01 |
| Not Yet Recruiting | Wet Heparinized Suction for Abdominal Cancer Cancer of Pancreas, Cancer of Stomach, Cancer of Esophagus | N/A | 2026-03-15 |
| Suspended | Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila Gynecologic Cancer, Genitourinary Cancer | N/A | 2026-03-01 |
| Not Yet Recruiting | Intermittent Fasting for Pancreatitis Pancreatitis, Pancreatitis, Acute, Pancreatitis, Chronic | N/A | 2026-03-01 |
| Recruiting | Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors Peritoneal Carcinomatosis | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors Smoking Cessation, Alcohol Use | N/A | 2026-02-01 |
| Recruiting | Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes Metastatic Ewing Sarcoma | Phase 1 | 2026-02-01 |
| Not Yet Recruiting | Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer Breast Cancer | Phase 3 | 2026-02-01 |
| Recruiting | Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | Phase 1 | 2026-01-21 |
| Recruiting | Digoxin Medulloblastoma Study Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH | Phase 2 | 2026-01-15 |
| Recruiting | Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma Metastatic Uveal Melanoma | Phase 2 | 2025-12-31 |
| Recruiting | Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma Melanoma | Phase 1 / Phase 2 | 2025-12-03 |
| Recruiting | Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs Skin Cancer | N/A | 2025-10-10 |
| Recruiting | A First-in-Human Study of FID-022 in Solid Tumor Patients Pancreatic Cancer, Cancer Cachexia | — | 2025-10-08 |
| Recruiting | Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) Cutaneous T Cell Lymphoma | Phase 1 | 2025-08-27 |
| Recruiting | Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) | — | 2025-07-17 |
| Recruiting | The MIND-BC Study: MIND Diet for Breast Cancer Cognition Breast Cancer | N/A | 2025-07-09 |
| Suspended | Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Bladder Cancer | Phase 1 | 2025-06-24 |
| Recruiting | Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma Cutaneous Sarcoma | Phase 2 | 2025-06-20 |
| Recruiting | Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC Non-small Cell Lung Cancer | Phase 2 | 2025-06-13 |
| Recruiting | Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors Lymphocytes | Phase 1 | 2025-06-02 |
| Recruiting | Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma Myeloma | Phase 2 | 2025-05-27 |
| Recruiting | ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area Cancer | N/A | 2025-05-22 |
| Active Not Recruiting | NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention Cancer, Nos | N/A | 2025-04-04 |
| Recruiting | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC Metastatic Colorectal Cancer, Hepatocellular Carcinoma | Phase 2 | 2025-04-01 |
| Recruiting | Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients Smoking Cessation | N/A | 2025-03-28 |
| Recruiting | Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym Large B-cell Lymphoma | Phase 2 | 2025-03-19 |
| Recruiting | Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC Head and Neck Squamous Cell Carcinoma | Phase 2 | 2025-02-26 |
| Suspended | Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 2 | 2025-02-25 |
| Recruiting | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer Breast Cancer, Node-positive Breast Cancer | Phase 2 | 2025-02-24 |
| Active Not Recruiting | Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center Pancreatic Ductal Adenocarcinoma, Intraductal Papillary Mucinous Neoplasm | N/A | 2025-02-19 |
| Active Not Recruiting | Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer Metastatic Castration Sensitive Prostate Cancer | Phase 2 | 2025-01-10 |
| Recruiting | Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy Chronic Graft-versus-host Disease (cGVHD) | Phase 2 | 2024-12-23 |
| Recruiting | Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer Wit Breast Cancer, Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2024-12-19 |
| Recruiting | BCL2i CLAG-M in R/R Acute Myeloid Leukemia Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 2 | 2024-11-26 |
| Recruiting | Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD Acute Myeloid Leukemia | Phase 2 | 2024-11-07 |
| Recruiting | Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma Metastatic Uveal Melanoma | Phase 2 | 2024-11-04 |
| Recruiting | Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer Breast Cancer Metastatic Breast Cancer, HER2-negative Breast Cancer | Phase 1 | 2024-11-04 |
| Recruiting | Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2024-10-26 |
| Recruiting | Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening Colorectal Cancer Screening, Hepatitis C Virus | N/A | 2024-10-21 |
| Recruiting | A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC Head and Neck Squamous Cell Carcinoma | Phase 2 | 2024-09-25 |
| Recruiting | Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S) Cancer | N/A | 2024-09-18 |
| Recruiting | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL Mantle Cell Lymphoma | Phase 2 | 2024-08-23 |
| Recruiting | Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer Metastatic Breast Cancer | Phase 2 | 2024-08-14 |
| Suspended | Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) Non Small Cell Lung Cancer, Lung Cancer | Phase 1 / Phase 2 | 2024-08-07 |
| Recruiting | Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer GastroEsophageal Cancer | N/A | 2024-07-26 |
| Withdrawn | Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG) Recurrent High-grade Glioma | Phase 1 | 2024-07-22 |
| Active Not Recruiting | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) Neoplasm of Pancreas, IPMN, Pancreatic | Phase 2 | 2024-07-09 |
| Recruiting | Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy Breast Cancer, Triple Negative Breast Cancer | EARLY_Phase 1 | 2024-06-12 |
| Completed | Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors Any Cancer Type | Phase 1 | 2024-06-12 |
| Recruiting | App for Reducing Cravings to Smoke Smoking | Phase 2 | 2024-06-11 |
| Recruiting | Exercise Prehabilitation for Locoregional Esophageal Cancer Esophageal Cancer | N/A | 2024-05-21 |
| Recruiting | Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma Melanoma Stage III, Melanoma Stage IV, Advanced Melanoma | Phase 2 | 2024-05-17 |
| Recruiting | Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutiona Pediatric Cancer | — | 2024-05-01 |
| Recruiting | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell Lymphoma | Phase 2 | 2024-04-19 |
| Completed | Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer Pancreatic Cancer, Locally Advanced Pancreatic Cancer | Phase 1 | 2024-04-10 |
| Recruiting | High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial) Rectal Cancer, Non-Small Cell Lung Cancer | N/A | 2024-04-04 |
| Completed | Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study Pancreatic Cancer | EARLY_Phase 1 | 2024-04-01 |
| Active Not Recruiting | TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC Squamous Cell Carcinoma of Head and Neck, Metastatic Squamous Cell Carcinoma | Phase 1 | 2024-03-14 |
| Recruiting | Avapritinib With Decitabine in Patients With SM-AHN Systemic Mastocytosis With an Associated Hematologic Neoplasm | Phase 1 | 2024-03-13 |
| Active Not Recruiting | Study of CG0070 After Transurethral Resection in Patients With IR NMIBC Non-muscle Invasive Bladder Cancer | Phase 1 | 2024-03-01 |
| Recruiting | Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer Pancreatic Cancer | N/A | 2024-02-09 |
| Active Not Recruiting | Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer Lung Cancer | — | 2024-02-05 |
| Recruiting | Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) Oropharyngeal Cancer, HPV-Related Carcinoma | — | 2024-01-22 |
| Active Not Recruiting | Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Too Breast Cancer, Obesity | N/A | 2024-01-20 |
| Suspended | Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) Mycosis Fungoides | EARLY_Phase 1 | 2024-01-18 |
| Recruiting | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer GastroEsophageal Cancer, Gastric Cancer | Phase 2 | 2024-01-12 |
| Recruiting | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | 2023-12-26 |
| Recruiting | Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC Squamous Cell Carcinoma, Head and Neck Cancer | Phase 2 | 2023-12-14 |
| Active Not Recruiting | REFLECT: Reproductive Education and Fertility Links for Cancer Treatment Reproductive Behavior | — | 2023-12-11 |
| Suspended | Non-Invasive Biomarkers in Prostate Cancer Disease Management Prostate Cancer | — | 2023-11-21 |
| Recruiting | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma | Phase 2 | 2023-11-08 |
| Completed | Aim 1: App for Reducing Cravings to Smoke Smoking | N/A | 2023-10-09 |
| Active Not Recruiting | The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response Pancreatic Cancer | N/A | 2023-09-12 |
| Completed | Enhancing Cancer Survivorship With Pickleball Cancer | N/A | 2023-09-11 |
| Recruiting | A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer | Phase 1 | 2023-08-22 |
| Recruiting | Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) Pancreatic Cancer | N/A | 2023-08-14 |
| Active Not Recruiting | Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma | Phase 1 | 2023-08-10 |
| Active Not Recruiting | Senior Adult Hepatobiliary Prehab Study Hepatobiliary Cancer, Cholangiocarcinoma, Liver Metastases | N/A | 2023-06-26 |
| Completed | Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases Metastatic Melanoma, Metastasis to Brain | EARLY_Phase 1 | 2023-06-06 |
| Completed | Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III | EARLY_Phase 1 | 2023-05-25 |
| Recruiting | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy Diffuse Large B Cell Lymphoma | Phase 2 | 2023-05-19 |
| Recruiting | CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia | Phase 1 | 2023-05-01 |
| Active Not Recruiting | The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors Oral Cavity Cancer, Oropharynx Cancer, Hypopharynx Cancer | N/A | 2023-04-06 |
| Recruiting | Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma Advanced Basal Cell Carcinoma | EARLY_Phase 1 | 2023-03-23 |
| Recruiting | Outreach Core Activities Cancer Education, Spanish Language Cancer Education | — | 2023-03-22 |
| Recruiting | Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer | Phase 1 | 2023-03-10 |
| Recruiting | Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations Pancreatic Cancer | — | 2023-02-22 |
| Completed | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunot Lymphoma, Leukemia, Myeloma | N/A | 2023-02-21 |
| Recruiting | Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Anemia | Phase 2 | 2023-02-21 |
| Recruiting | Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology Gastrointestinal Cancer | Phase 1 / Phase 2 | 2023-02-20 |
| Recruiting | CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML Acute Myeloid Leukemia | Phase 1 | 2023-02-16 |
| Terminated | Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) Large Granular Lymphocyte Leukemia | EARLY_Phase 1 | 2023-02-15 |
| Recruiting | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer Prostate Cancer, Metastatic Prostate Cancer | Phase 2 | 2023-02-14 |
| Completed | Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and S Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | 2023-01-25 |
| Recruiting | Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer Triple Negative Breast Cancer | Phase 2 | 2023-01-25 |
| Recruiting | Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS Smoking Cessation, HIV | N/A | 2023-01-11 |
| Recruiting | Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance o Lung; Node, Adenocarcinoma of Lung | — | 2023-01-11 |
| Suspended | HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) Human Papilloma Virus (HPV) Vaccine | N/A | 2023-01-09 |
| Recruiting | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma Penile Carcinoma | Phase 2 | 2022-12-28 |
| Active Not Recruiting | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients Pancreatic Cancer | N/A | 2022-12-21 |
| Completed | STRONG Program for Cancer Patients Gastrointestinal Cancer | N/A | 2022-12-01 |
| Active Not Recruiting | Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) Smoking Cessation, Cervical Cancer, High Grade Cervical Dysplasia | N/A | 2022-11-29 |
| Completed | Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma | Phase 1 | 2022-11-22 |
| Completed | Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immuno Renal Cell Carcinoma Stage IV | — | 2022-10-19 |
| Recruiting | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma Uveal Melanoma, Ocular Melanoma | Phase 2 | 2022-10-11 |
| Active Not Recruiting | The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics Pancreatic Ductal Adenocarcinoma, Pancreatic Cyst, Chronic Pancreatitis | — | 2022-10-06 |
| Recruiting | DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer Triple Negative Breast Cancer, HER2-negative Breast Cancer | Phase 1 | 2022-08-26 |
| Completed | Exploring Men s Prostate Cancer Genetic Risk Perceptions Prostate Cancer | — | 2022-08-25 |
| Completed | Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer Pancreatic Cancer | N/A | 2022-07-15 |
| Active Not Recruiting | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) P GastroEsophageal Cancer | N/A | 2022-07-15 |
| Active Not Recruiting | Exercise to Boost Response to Checkpoint Blockade Immunotherapy Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma | EARLY_Phase 1 | 2022-06-21 |
| Active Not Recruiting | "COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors Health Behavior | — | 2022-06-20 |
| Recruiting | Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ M HER2-positive Breast Cancer | Phase 1 | 2022-05-31 |
| Recruiting | Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma High Grade Sarcoma | Phase 2 | 2022-05-18 |
| Completed | Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life Stress, Quality of Life, Sleep Disturbance | N/A | 2022-05-11 |
| Recruiting | Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer Ovarian Cancer | Phase 1 | 2022-04-28 |
| Active Not Recruiting | Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant Multiple Myeloma | — | 2022-04-20 |
| Active Not Recruiting | Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT Acute Myeloid Leukemia | Phase 1 | 2022-03-21 |
| Terminated | Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms Myeloproliferative Neoplasm | Phase 1 | 2022-03-14 |
| Active Not Recruiting | Preop fSRS for Resectable Brain Metastases Brain Metastases, Brain Lesion | Phase 2 | 2022-03-11 |
| Active Not Recruiting | DASH INtervention to INvestigate the Gut Microbiota, Cancer | N/A | 2022-03-07 |
| Active Not Recruiting | Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) Myeloproliferative Neoplasm, Chronic Neutrophilic Leukemia, MDS | Phase 2 | 2022-03-01 |
| Recruiting | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML Acute Myeloid Leukemia With FLT3/ITD Mutation | Phase 1 | 2022-02-25 |
| Active Not Recruiting | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization Prostate Carcinoma, Benign Prostatic Hyperplasia | Phase 2 | 2022-02-23 |
| Active Not Recruiting | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | 2022-01-25 |
| Active Not Recruiting | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma Rectal Adenocarcinoma | EARLY_Phase 1 | 2021-12-23 |
| Recruiting | Study of Screening Brain MRIs in Stage IV Breast Cancer Triple Negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer | — | 2021-12-21 |
| Active Not Recruiting | Automated Video-Assisted Smoking Treatment for People Living With HIV Smoking Cessation | N/A | 2021-12-15 |
| Active Not Recruiting | Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma Metastatic Uveal Melanoma | Phase 2 | 2021-12-15 |
| Completed | Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers Smoking Cessation | N/A | 2021-12-01 |
| Recruiting | Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases Brain Metastases, HR+ Metastatic Breast Cancer | Phase 1 / Phase 2 | 2021-11-30 |
| Completed | Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma | Phase 1 | 2021-11-18 |
| Completed | Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Gynecologic Cancer, Prostate Cancer, Patient Satisfaction | — | 2021-11-16 |
| Terminated | SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 | 2021-11-03 |
| Recruiting | Using Aspirin to Improve Immunological Features of Ovarian Tumors Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | EARLY_Phase 1 | 2021-11-02 |
| Completed | CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers Hepatitis C Virus Infection, Colorectal Cancer | — | 2021-11-01 |
| Recruiting | Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab HER2-positive Breast Cancer | Phase 2 | 2021-10-28 |
| Active Not Recruiting | Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Adv Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma | Phase 1 | 2021-10-22 |
| Completed | Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome Head and Neck Cancer | N/A | 2021-10-20 |
| Active Not Recruiting | Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools Obesity | N/A | 2021-10-12 |
| Completed | Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer Hormone Receptor-positive Breast Cancer | Phase 1 | 2021-10-12 |
| Recruiting | Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma Squamous Cell Carcinoma | Phase 2 | 2021-10-01 |
| Active Not Recruiting | Evaluating Stress Management Among Allogeneic HCT Caregivers Burden, Stress | N/A | 2021-09-16 |
| Completed | COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients Covid19, SARS-CoV2 Infection | — | 2021-09-10 |
| Active Not Recruiting | NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies Surgical Wound Infection | Phase 2 / Phase 3 | 2021-08-05 |
| Recruiting | Axitinib + Ipilimumab in Advanced Melanoma Melanoma | Phase 2 | 2021-08-04 |
| Completed | Adaptation Of An HPV Education Resource To Promote HPV Vaccination HPV Vaccine, HPV | — | 2021-07-23 |
| Completed | Clinical Trials Outreach & Education Knowledge, Attitudes, Practice | N/A | 2021-06-15 |
| Completed | Motivating a Spectrum of Cancer Patients to Quit Smoking Cancer, Smoking | N/A | 2021-06-14 |
| Completed | Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free Smoking, Tobacco Use, Lung Cancer | N/A | 2021-06-07 |
| Active Not Recruiting | Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin | Phase 2 | 2021-05-28 |
| Recruiting | Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation | EARLY_Phase 1 | 2021-05-24 |
| Completed | Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors Cancer Survivor, Young Adult | N/A | 2021-05-11 |
| Active Not Recruiting | Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Pat Metastatic Urothelial Carcinoma | Phase 1 / Phase 2 | 2021-04-30 |
| Withdrawn | Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer Pancreatic Cancer, Resectable Pancreatic Cancer | EARLY_Phase 1 | 2021-04-01 |
| Active Not Recruiting | Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2021-03-30 |
| Active Not Recruiting | Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) | Phase 2 | 2021-02-18 |
| Completed | Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults HPV Vaccine Knowledge | — | 2021-02-17 |
| Completed | CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2021-01-14 |
| Active Not Recruiting | Evolutionary Therapy for Rhabdomyosarcoma Rhabdomyosarcoma | Phase 2 | 2020-12-29 |
| Completed | Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients Melanoma | Phase 2 | 2020-12-22 |
| Completed | Addressing Barriers to Palliative Care Use in Bladder Cancer Muscle-Invasive Bladder Carcinoma, Bladder Cancer Stage II, Bladder Cancer Stage III | — | 2020-12-22 |
| Recruiting | Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease | Phase 1 / Phase 2 | 2020-12-10 |
| Withdrawn | PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient Breast Cancer, Breast Cancer, Female, Breast Cancer, Male | EARLY_Phase 1 | 2020-12-01 |
| Terminated | Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 1 | 2020-11-23 |
| Completed | Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses Breast Cancer | — | 2020-10-27 |
| Completed | Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC Muscle-Invasive Bladder Carcinoma, Bladder Cancer | Phase 1 | 2020-10-26 |
| Completed | SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida Coronavirus Infection | — | 2020-10-17 |
| Withdrawn | Cryotherapy for GAVE GAVE - Gastric Antral Vascular Ectasia, Bleeding, Bleeding Gastric | N/A | 2020-10-14 |
| Recruiting | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients Melanoma Stage III, Melanoma Stage IV, Inoperable Disease | Phase 2 | 2020-09-24 |
| Active Not Recruiting | Clinical Trial of Green Tea Catechins in Men on Active Surveillance Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | 2020-08-21 |
| Active Not Recruiting | Quality of Life Model for Older Patients With AML AML, Adult, Acute Myeloid Leukemia | — | 2020-07-08 |
| Withdrawn | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer Non Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer | Phase 2 | 2020-07-01 |
| Active Not Recruiting | Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for H Colorectal Cancer | — | 2020-06-25 |
| Terminated | Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2020-06-25 |
| Recruiting | Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board Incurable Disease | — | 2020-05-05 |
| Withdrawn | Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention Bladder Cancer, Bladder Tumor, Urothelial Carcinoma | Phase 2 | 2020-04-01 |
| Completed | Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes Diffuse Large B Cell Lymphoma, Transformed Lymphoma | — | 2020-03-10 |
| Terminated | Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE Hepatocellular Carcinoma, Liver Cancer | EARLY_Phase 1 | 2020-02-19 |
| Recruiting | Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas Pancreatic Cancer, Pancreatic Cyst | — | 2020-02-18 |
| Completed | Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator Brain Cancer | N/A | 2020-02-13 |
| Completed | Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk Breast Cancer | — | 2020-01-30 |
| Withdrawn | Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study Cutaneous Squamous Cell Carcinoma | EARLY_Phase 1 | 2020-01-30 |
| Completed | Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN) Chemotherapy-induced Peripheral Neuropathy | N/A | 2020-01-23 |
| Recruiting | PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores Prostate Cancer, Recurrent Prostate Cancer | Phase 2 / Phase 3 | 2019-12-18 |
| Completed | Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia | Phase 2 | 2019-12-06 |
| Active Not Recruiting | Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 2 | 2019-11-22 |
| Active Not Recruiting | Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors Chronic Phase Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase | Phase 2 | 2019-11-19 |
| Terminated | TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia | Phase 2 | 2019-11-12 |
| Completed | Utilizing Augmented Reality as an Adjunct for Smoking Cessation Smoking | N/A | 2019-10-07 |
| Active Not Recruiting | Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent | Phase 1 | 2019-10-03 |
| Completed | Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Sof Sarcoma | Phase 1 | 2019-09-27 |
| Completed | Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract Neuroendocrine Carcinoma | — | 2019-09-25 |
| Completed | Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery GI Cancer, Nutritional Deficiency | — | 2019-09-23 |
| Active Not Recruiting | Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion Chronic Myelomonocytic Leukemia, Leukemia | Phase 2 | 2019-08-28 |
| Completed | IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma | Phase 1 | 2019-08-21 |
| Terminated | Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma Angiosarcoma of Skin | Phase 2 | 2019-08-20 |
| Completed | Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance Sleep Disturbance | N/A | 2019-08-15 |
| Completed | Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas Brain Tumor, Glioma | — | 2019-08-15 |
| Terminated | Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma Glioma of Brain | EARLY_Phase 1 | 2019-06-20 |
| Completed | Avelumab With Radiotherapy in Patients With Leptomeningeal Disease Leptomeningeal Metastases, Leptomeningeal Disease | Phase 1 | 2019-06-10 |
| Active Not Recruiting | Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer | Phase 1 | 2019-06-06 |
| Active Not Recruiting | Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers Lung Diseases, Lung Cancer, Protection Against | Phase 2 | 2019-06-05 |
| Terminated | Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 2 | 2019-05-31 |
| Completed | Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma Melanoma | Phase 2 | 2019-05-14 |
| Terminated | Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | 2019-04-26 |
| Terminated | Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2019-04-18 |
| Completed | Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia Hyperglycemia | EARLY_Phase 1 | 2019-04-04 |
| Active Not Recruiting | Florida Pancreas Collaborative Next Generation Biobank Pancreatic Cancer, Cancer Cachexia | — | 2019-03-04 |
| Completed | CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease Graft-versus-host-disease, GVHD, GVHD, Acute | Phase 1 | 2019-02-15 |
| Completed | IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors Metastatic Cancer, Recurrent Cancer, Solid Tumor | Phase 1 | 2019-02-13 |
| Active Not Recruiting | Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC Non-small Cell Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer Metastatic | Phase 1 | 2019-02-01 |
| Completed | Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases Metastatic Breast Cancer, Brain Metastases | Phase 1 | 2019-01-30 |
| Completed | Emotional Support Messages Following a Cancer Diagnosis Psychological Stress, Anxiety | — | 2019-01-30 |
| Active Not Recruiting | SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic | Phase 2 | 2019-01-29 |
| Completed | Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation Tobacco Use, Alcohol Use, Unspecified | N/A | 2019-01-14 |
| Terminated | Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 Breast Cancer, HER2-positive Breast Cancer, HER-2 Gene Amplification | Phase 2 | 2019-01-10 |
| Completed | TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Ade Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Gastric Cancer | Phase 2 | 2018-12-20 |
| Terminated | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non- Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2018-11-20 |
| Withdrawn | Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 P Prostate Cancer | N/A | 2018-11-19 |
| Completed | Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer Colorectal Cancer, Metastatic Colorectal Cancer, Colon Cancer | Phase 1 | 2018-10-23 |
| Completed | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 2 | 2018-10-11 |
| Terminated | Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide Multiple Myeloma | Phase 2 | 2018-10-04 |
| Active Not Recruiting | Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy Prostate Cancer, Prostate Disease | Phase 1 / Phase 2 | 2018-10-03 |
| Completed | Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers Oropharyngeal Cancer | N/A | 2018-09-26 |
| Active Not Recruiting | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer Prostate Cancer, Stage IV Prostate Cancer, Advanced Prostate Cancer | EARLY_Phase 1 | 2018-09-17 |
| Completed | Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients Depression, Anxiety, Generalized Anxiety Disorder | N/A | 2018-09-12 |
| Terminated | Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer | Phase 2 | 2018-08-06 |
| Completed | Applying mHealth to Tobacco-related Health Disparities Smoking Cessation | EARLY_Phase 1 | 2018-07-16 |
| Withdrawn | Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung Lung Cancer, Adenocarcinoma of the Lung | Phase 1 / Phase 2 | 2018-07-01 |
| Completed | Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma Melanoma, Unresectable Melanoma, Advanced Melanoma | Phase 1 | 2018-06-27 |
| Active Not Recruiting | Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Melanoma (Skin), Skin Cancer, Skin Melanoma | EARLY_Phase 1 | 2018-06-14 |
| Active Not Recruiting | HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer Breast Cancer, Breast Cancer Female, Breast Cancer, Male | EARLY_Phase 1 | 2018-06-06 |
| Completed | Improving Sleep in BMT Survivors Sleep Disturbance, Sleep Disorder | N/A | 2018-05-15 |
| Completed | Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES) Colorectal Cancer | — | 2018-04-03 |
| Completed | Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma Glioblastoma, Brain Tumor, GBM | Phase 1 | 2018-03-16 |
| Terminated | Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer ( Small Cell Lung Cancer, Lung Cancer, Relapsed Small Cell Lung Cancer | Phase 2 | 2018-03-15 |
| Active Not Recruiting | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I | Phase 2 | 2018-02-19 |
| Active Not Recruiting | Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer Non Small Cell Lung Cancer, Lung Cancer, Nonsmall Cell, Non Small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | 2018-02-02 |
| Completed | Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers Colon Cancer, Colorectal Cancer, Colorectal Carcinoma | Phase 1 / Phase 2 | 2018-01-24 |
| Completed | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity | Phase 1 / Phase 2 | 2017-12-20 |
| Completed | Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer | Phase 2 | 2017-12-15 |
| Terminated | Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma | N/A | 2017-11-29 |
| Completed | Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Squamous Cell Carcinoma | Phase 1 | 2017-10-11 |
| Completed | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC Lung Cancer, Non Small Cell Lung Cancer, Advanced Cancer | Phase 1 | 2017-09-26 |
| Completed | Facilitating Smoking Cessation With Reduced Nicotine Cigarettes Smoking Cessation | Phase 2 | 2017-09-07 |
| Completed | Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Mye Multiple Myeloma | Phase 1 / Phase 2 | 2017-07-20 |
| Completed | Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer Breast Cancer, Breast Cancer, Male, Breast Cancer Female | Phase 1 / Phase 2 | 2017-06-23 |
| Completed | Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population Cancer | N/A | 2017-06-13 |
| Completed | A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression Graft Vs Host Disease, GVHD | Phase 1 / Phase 2 | 2017-06-08 |
| Withdrawn | Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat Multiple Myeloma | Phase 1 / Phase 2 | 2017-06-01 |
| Completed | Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Neoplasm | Phase 1 / Phase 2 | 2017-05-18 |
| Completed | Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative Colorectal Cancer | N/A | 2017-05-11 |
| Completed | Refining and Testing the Electronic Social Network Assessment Program (eSNAP) Brain Cancer | — | 2017-05-05 |
| Completed | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma | Phase 1 / Phase 2 | 2017-05-02 |
| Completed | Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 2017-04-25 |
| Withdrawn | Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma HepatoCellular Carcinoma, Unresectable HepatoCellular Carcinoma, Liver Cancer | Phase 1 | 2017-03-27 |
| Completed | Biobank for African American Prostate Cancer Research in Florida Prostate Cancer | — | 2017-03-22 |
| Active Not Recruiting | Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma Merkel Cell Carcinoma, Skin Cancer | Phase 2 | 2017-03-14 |
| Completed | Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study Lung Cancer, Non-small Cell Lung Cancer | — | 2017-02-16 |
| Terminated | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Carcinoma in Situ of Bladder, Bladder Cancer | Phase 2 | 2017-02-16 |
| Completed | Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer | Phase 1 / Phase 2 | 2017-02-13 |
| Terminated | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Gastro-enteropancreatic Neuroendocrine Tumor, Pancreatic Cancer, Neuroendocrine Carcinomas of Pancreas | Phase 2 | 2017-02-01 |
| Completed | Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia | Phase 1 | 2017-01-31 |
| Completed | Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors Gastroenteropancreatic Neuroendocrine Tumor, Lung Neuroendocrine Neoplasm | — | 2017-01-09 |
| Completed | Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma | Phase 2 | 2016-10-25 |
| Completed | Spanish-Language Smoking Cessation Trial Smoking Cessation | N/A | 2016-10-24 |
| Completed | Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | — | 2016-10-20 |
| Completed | Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma Rectal Cancer, Rectal Adenocarcinoma | Phase 1 | 2016-10-14 |
| Completed | Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers Biliary Tract Cancer, Biliary Tract Neoplasms | Phase 2 | 2016-10-05 |
| Completed | Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) Multiple Myeloma | EARLY_Phase 1 | 2016-09-27 |
| Active Not Recruiting | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma Melanoma, Skin Cancer | Phase 1 | 2016-09-07 |
| Completed | Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurren Malignant Glioma | Phase 1 | 2016-08-22 |
| Completed | Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma | Phase 2 | 2016-07-05 |
| Completed | Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT) Multiple Myeloma | Phase 2 | 2016-06-10 |
| Withdrawn | A Combined Cell Therapy Approach to the Treatment of Neuroblastoma Neuroblastoma, Neoplasms, Nerve Tissue | Phase 1 | 2016-04-14 |
| Active Not Recruiting | Validation Study on the Impact of Decipher® Testing - VANDAAM Study Prostate Cancer | — | 2016-04-13 |
| Active Not Recruiting | Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) Lung Cancer, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-03-22 |
| Completed | Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma Melanoma (Skin), Skin Cancer | EARLY_Phase 1 | 2016-03-08 |
| Completed | Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma Malignant Pleural Mesothelioma, Mesothelioma | Phase 2 | 2016-03-04 |
| Completed | Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention Graft Versus Host Disease, GVHD | Phase 2 | 2016-03-04 |
| Terminated | Fermented Wheat Germ Extract in Women With Ovarian Cancer Ovarian Cancer | EARLY_Phase 1 | 2016-03-01 |
| Completed | TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer Breast Cancer, Breast Cancer - Female, Breast Cancer - Male | Phase 1 | 2016-02-23 |
| Completed | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclop Breast Cancer, Breast Cancer Female | Phase 4 | 2016-02-09 |
| Completed | Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer Prostate Cancer | Phase 1 | 2016-01-27 |
| Completed | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer Ovarian Cancer | Phase 2 | 2015-10-20 |
| Completed | Smoking-cessation: A Spanish-Language Clinical Trial Smoking Cessation, Tobacco Dependence | N/A | 2015-10-15 |
| Completed | AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer Lung Cancer | Phase 2 | 2015-10-13 |
| Completed | Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors Carcinoid Tumors, Pancreatic NET | Phase 2 | 2015-10-09 |
| Completed | Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention Chronic Myelogenous Leukemia | N/A | 2015-09-29 |
| Completed | Using MC1R Genotype to Impact Melanoma Risk Behavior Melanoma (Skin), Squamous Cell Carcinoma, Squamous Cell Cancer | N/A | 2015-08-03 |
| Completed | Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Malignant Glioma | Phase 1 | 2015-07-28 |
| Completed | Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 Prostate Cancer, Prostate Adenocarcinoma | — | 2015-07-22 |
| Completed | Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) Breast Cancer | Phase 2 | 2015-07-08 |
| Completed | A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML Leukemia, Acute Myeloid Leukemia, AML | Phase 1 | 2015-06-18 |
| Active Not Recruiting | Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer Prostate Cancer | EARLY_Phase 1 | 2015-04-13 |
| Completed | Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes Smoking Cessation | N/A | 2015-03-31 |
| Completed | Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database Oncology Problem | — | 2015-03-19 |
| Completed | Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer Hepatocellular Cancer, Liver Cancer | Phase 1 | 2015-02-18 |
| Completed | Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer Bladder Cancer, Carcinoma, Transitional Cell, Renal Pelvis Cancer | Phase 1 | 2015-02-11 |
| Completed | Smoking Cessation for Cervical Cancer Survivors Cervical Cancer, Tobacco Use, Smoking Cessation | N/A | 2015-01-01 |
| Completed | Focal Prostate Radio-Frequency Ablation Prostate Cancer | N/A | 2014-12-29 |
| Terminated | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus Esophageal Cancer, Gastric Cancer | Phase 1 | 2014-12-01 |
| Completed | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Canc Pancreatic Cancer | Phase 1 | 2014-10-30 |
| Completed | Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease Graft Versus Host Disease | Phase 1 | 2014-10-29 |
| Completed | Capitalizing on a Teachable Moment to Promote Smoking Cessation Smoking Cessation | N/A | 2014-10-20 |
| Terminated | Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases Brain Metastases, Generalized Malignancy, Primary, Brain Lesions | Phase 1 | 2014-10-09 |
| Completed | HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Breast Cancer | Phase 1 | 2014-10-01 |
| Withdrawn | Biomarker Correlates of Hypoxia in Metastatic Melanoma Melanoma, Skin Cancer | Phase 2 | 2014-10-01 |
| Completed | Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2014-09-23 |
| Completed | Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Breast Cancer | Phase 1 / Phase 2 | 2014-09-05 |
| Completed | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Car Squamous Cell Carcinoma of Skin, Carcinoma, Squamous Cell | Phase 2 | 2014-08-12 |
| Completed | COGNUTRIN in Breast Cancer Survivors Breast Cancer | EARLY_Phase 1 | 2014-07-30 |
| Completed | Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence Smoking Cessation, Tobacco Dependence | EARLY_Phase 1 | 2014-07-17 |
| Completed | Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2014-07-16 |
| Completed | Single Agent Regorafenib in Refractory Advanced Biliary Cancers Cancer of the Bile Duct | Phase 2 | 2014-06-05 |
| Completed | Navigator Guided e-Psychoeducational Intervention Prostate Cancer | — | 2014-06-02 |
| Withdrawn | A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS Breast Cancer | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cance Pancreatic Cancer | Phase 1 | 2014-05-22 |
| Completed | Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) Colorectal Cancer, Colorectal Carcinoma | N/A | 2014-04-28 |
| Completed | HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy Breast Cancer | Phase 1 | 2014-04-08 |
| Terminated | Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 Peripheral T-Cell Lymphoma | N/A | 2014-04-01 |
| Completed | In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis Graft-Versus-Host-Disease | Phase 2 | 2014-03-25 |
| Completed | Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma Melanoma, Skin Cancer | Phase 1 | 2014-01-07 |
| Completed | Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) Lung Cancer, Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2013-12-31 |
| Completed | A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation Lung Cancer, Non-Small Cell Lung Cancer | Phase 1 | 2013-12-30 |
| Completed | Physical Activity for Advanced Stage Cancer Patients Cancer | N/A | 2013-12-12 |
| Terminated | P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome Neuroendocrine Carcinoma | Phase 2 | 2013-12-01 |
| Terminated | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain Tumor, Cancer, Pain | Phase 1 | 2013-09-01 |
| Completed | Yoga for Aromatase Inhibitor-associated Joint Pain Breast Cancer | N/A | 2013-09-01 |
| Completed | Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 2 | 2013-08-29 |
| Completed | Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection Dysphagia | N/A | 2013-07-18 |
| Completed | Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS) Myelodysplastic Syndromes | Phase 2 | 2013-07-01 |
| Completed | Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer Prostate Cancer | N/A | 2013-04-11 |
| Withdrawn | Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly Lymphoma | N/A | 2013-03-01 |
| Completed | Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Ho Graft vs. Host Disease | Phase 2 | 2013-02-25 |
| Completed | Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients Chronic Phase Chronic Myeloid Leukemia | Phase 1 | 2013-02-21 |
| Completed | A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib Myelomonocytic Leukemia | Phase 1 / Phase 2 | 2013-02-20 |
| Completed | Study of Gardasil in Mid-Adult Males (MAM) Human Papillomavirus | Phase 2 | 2013-02-19 |
| Completed | A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients Breast Cancer | Phase 1 | 2013-02-06 |
| Terminated | GTX-RT in Borderline Resectable Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2013-02-01 |
| Completed | Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant Multiple Myeloma | N/A | 2013-02-01 |
| Completed | Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study Melanoma | Phase 1 | 2013-01-24 |
| Withdrawn | C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer Breast Cancer | N/A | 2013-01-01 |
| Completed | Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Solid Tumor | Phase 1 | 2013-01-01 |
| Completed | Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease Chronic Graft Versus Host Disease | Phase 1 / Phase 2 | 2012-11-14 |
| Completed | Pilot Study of Regional Lung Ventilation Non-small Cell Lung Cancer | N/A | 2012-10-15 |
| Completed | Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts Metastatic Melanoma | N/A | 2012-10-09 |
| Completed | Metformin in Children With Relapsed or Refractory Solid Tumors Solid Tumors, Primary Brain Tumors | Phase 1 | 2012-09-24 |
| Completed | Preparedness Study - HPV Vaccine Sexual Transmission of Infection | N/A | 2012-09-01 |
| Completed | Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma Metastatic Melanoma | Phase 2 | 2012-08-03 |
| Completed | Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma Melanoma | Phase 1 | 2012-07-27 |
| Completed | Genetic Counseling for Breast Cancer Survivors (GC for BC) Breast Cancer | N/A | 2012-07-27 |
| Completed | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma Urothelial Carcinoma | Phase 1 | 2012-07-01 |
| Terminated | Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA Prostate Cancer | Phase 2 | 2012-05-01 |
| Completed | Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets Liver Cancer, Pancreatic Cancer | Phase 2 | 2012-04-01 |
| Completed | Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/ Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2012-03-30 |
| Completed | Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer Lung Cancer, Adenocarcinoma | Phase 1 / Phase 2 | 2012-03-26 |
| Completed | Stress Management Training for Latinas Receiving Chemotherapy Cancer, Stress | N/A | 2012-03-13 |
| Withdrawn | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer Pancreatic Tumor | N/A | 2012-03-01 |
| Completed | Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma Melanoma | Phase 1 | 2012-02-17 |
| Completed | Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2012-01-26 |
| Completed | Smoking Relapse-Prevention Intervention for Cancer Patients Smoking Cessation | N/A | 2012-01-04 |
| Completed | Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks Colorectal Cancer, Colorectal Carcinoma | N/A | 2011-12-05 |
| Completed | Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer Bladder Cancer | Phase 2 | 2011-11-30 |
| Completed | Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide Myeloma | Phase 1 / Phase 2 | 2011-11-01 |
| Completed | A Study of Axitinib in Advanced Carcinoid Tumors Carcinoid Tumor | Phase 2 | 2011-10-25 |
| Terminated | Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC Melanoma | Phase 2 | 2011-10-11 |
| Completed | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects Pancreatic Cancer | Phase 1 | 2011-10-01 |
| Completed | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects Pancreatic Cancer | Phase 1 | 2011-09-01 |
| Completed | Phase I Trial of Combination of FOLFIRI and SOM 230 Gastrointestinal Tumor | Phase 1 | 2011-09-01 |
| Completed | Pilot Study on Focal Prostate Radio-Frequency Ablation Prostate Cancer | N/A | 2011-08-01 |
| Completed | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acut Acute Lymphoblastic Leukemia | Phase 1 | 2011-07-18 |
| Completed | Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy Neuropathy, Gastrointestinal Cancer | N/A | 2011-07-01 |
| Completed | Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids Endometrial Cancer, Ovarian Cancer | Phase 1 | 2011-06-13 |
| Completed | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2011-06-01 |
| Completed | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer Rectal Cancer | Phase 1 | 2011-06-01 |
| Terminated | Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia Myelodysplastic Syndrome (MDS), Thrombocytopenia | Phase 1 | 2011-04-06 |
| Completed | Colorectal Cancer Awareness, Research, Education and Screening (CARES) Colorectal Cancer | N/A | 2011-02-11 |
| Completed | Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) Neuroendocrine Tumors, Carcinoid Tumors | Phase 2 | 2011-02-01 |
| Completed | Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma Cholangiocarcinoma | N/A | 2011-01-01 |
| Completed | Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) Soft Tissue Sarcoma | Phase 2 | 2011-01-01 |
| Terminated | Nuvigil or Placebo in Newly Diagnosed Malignant Glioma Malignant Glioma | Phase 2 | 2010-12-01 |
| Completed | Evaluating Biobanking Educational Tools Neoplasm | N/A | 2010-09-27 |
| Terminated | Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors Pancreatic Tumors | — | 2010-09-01 |
| Withdrawn | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2010-09-01 |
| Completed | Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Melanoma (Skin) | Phase 1 | 2010-08-13 |
| Completed | Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 Melanoma (Skin) | Phase 1 | 2010-08-04 |
| Completed | Promoting a Healthier Lifestyle Among Breast Cancer Survivors Breast Cancer | N/A | 2010-08-01 |
| Completed | Gem-TABS in Unresectable Pancreatic Carcinoma Pancreatic Cancer | Phase 1 | 2010-08-01 |
| Terminated | Bicarbonate for Tumor Related Pain Neoplasm Related Pain (Acute) (Chronic) | N/A | 2010-08-01 |
| Withdrawn | Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures Multiple Myeloma | N/A | 2010-07-01 |
| Completed | Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS Myelodysplastic Syndrome, MDS | Phase 2 | 2010-04-28 |
| Completed | Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host D Graft-Versus-Host Disease | Phase 1 / Phase 2 | 2010-04-01 |
| Terminated | Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Non-Hodgkin's Lymphoma | Phase 2 | 2010-03-01 |
| Completed | Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 2 | 2010-01-14 |
| Terminated | Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas Sarcoma | Phase 2 | 2010-01-01 |
| Completed | Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer Ovarian Cancer | N/A | 2010-01-01 |
| Completed | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer | Phase 1 / Phase 2 | 2009-12-28 |
| Completed | Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness Prostate Cancer | Phase 2 | 2009-12-11 |
| Completed | Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma Metastatic Melanoma | N/A | 2009-10-20 |
| Completed | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 Melanoma | Phase 1 | 2009-10-01 |
| Completed | Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia Pancreatic Neoplasms | Phase 1 | 2009-09-01 |
| Completed | Erlotinib Study for Myelodysplastic Syndrome (MDS) Myelodysplastic Syndrome | Phase 2 | 2009-09-01 |
| Terminated | Depocyt® With Sorafenib in Neoplastic Meningitis Neoplastic Meningitis | N/A | 2009-08-01 |
| Completed | CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) Leukemia | Phase 2 | 2009-08-01 |
| Completed | Facts and Attitudes About Clinical Trials Cancer, Neoplasm | N/A | 2009-07-01 |
| Completed | Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukem Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2009-06-25 |
| Completed | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Multiple Myeloma | Phase 2 | 2009-06-18 |
| Terminated | Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors Brain Metastases | Phase 1 | 2009-04-01 |
| Terminated | Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Mo Lung Cancer | Phase 2 | 2009-03-01 |
| Terminated | Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery Pancreatic Neoplasms | Phase 2 | 2009-03-01 |
| Completed | Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) Leukemia | Phase 1 | 2009-02-02 |
| Completed | Extended Self-Help for Smoking Cessation Smoking Cessation | N/A | 2009-01-23 |
| Completed | Liposuction for Arm Lymphedema Following Breast Cancer Surgery Breast Cancer | N/A | 2008-12-03 |
| Completed | PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Prostate Cancer | N/A | 2008-12-02 |
| Completed | Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery Colorectal Cancer | N/A | 2008-12-01 |
| Completed | Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline") Smoking Cessation | N/A | 2008-12-01 |
| Completed | Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers Lung Cancer, Head and Neck Cancer | Phase 1 | 2008-11-01 |
| Completed | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured Melanoma (Skin) | Phase 1 | 2008-11-01 |
| Completed | Managing Medication-induced Constipation in Cancer: A Clinical Trial Constipation | N/A | 2008-11-01 |
| Completed | Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement Tobacco Dependence | N/A | 2008-09-01 |
| Completed | Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2008-09-01 |
| Completed | Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantat Acute Graft Versus Host Disease | Phase 2 | 2008-09-01 |
| Completed | A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma Glioblastoma | Phase 1 | 2008-09-01 |
| Completed | Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection Cancer of the Urinary Tract | N/A | 2008-09-01 |
| Completed | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients Prostate Cancer | N/A | 2008-08-01 |
| Terminated | Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan Ovarian Cancer | N/A | 2008-07-01 |
| Completed | Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms Leukemia | N/A | 2008-06-01 |
| Completed | Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advan Lung Cancer | Phase 2 | 2008-04-01 |
| Completed | Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx Breast Cancer | — | 2008-03-01 |
| Completed | Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Alloge Leukemia | N/A | 2008-03-01 |
| Completed | Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts Myelodysplastic Syndromes | N/A | 2008-02-01 |
| Completed | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 2 | 2008-01-01 |
| Terminated | Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantatio Graft Versus Host Disease | Phase 2 | 2007-12-01 |
| Completed | Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia Prostatic Hyperplasia | Phase 2 | 2007-11-14 |
| Completed | A Phase I/II Study of Dasatinib and Dacarbazine Metastatic Melanoma | Phase 1 / Phase 2 | 2007-11-01 |
| Completed | To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid Small Cell Lung Cancer | Phase 2 | 2007-10-02 |
| Completed | Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab Lymphocytic Leukemia, Mantle Cell Lymphoma | Phase 2 | 2007-10-01 |
| Terminated | Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothe Mesothelioma | Phase 1 / Phase 2 | 2007-10-01 |
| Completed | Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer Pancreatic Cancer | — | 2007-08-23 |
| Completed | Effects of Yoga and Cardiovascular Exercise on Smoking Motivation Tobacco Dependence | N/A | 2007-08-21 |
| Terminated | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tu Pancreatic Cancer | Phase 2 | 2007-08-01 |
| Completed | A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia Cancer Cachexia | N/A | 2007-07-01 |
| Completed | Phase II Trial of Pentostatin and Targeted Busulfan Hematologic Malignancies | Phase 2 | 2007-07-01 |
| Terminated | Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem Lung Cancer | Phase 2 | 2007-06-01 |
| Terminated | Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cance Small Cell Lung Cancer | Phase 2 | 2007-05-01 |
| Completed | Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma Melanoma | Phase 2 | 2007-05-01 |
| Completed | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC Non-Small Cell Lung Cancer | Phase 3 | 2007-05-01 |
| Completed | Patient Navigator Project Breast Cancer, Colon Cancer | N/A | 2007-05-01 |
| Completed | A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer Metastatic Pancreatic Carcinoma | Phase 1 | 2007-04-01 |
| Completed | Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) Non-Small-Cell Lung Carcinoma | Phase 1 | 2007-03-01 |
| Completed | Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum | Phase 2 | 2007-03-01 |
| Completed | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma Anaplastic Astrocytoma, Glioblastoma | Phase 2 | 2007-03-01 |
| Terminated | Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases Brain Metastases | Phase 1 | 2006-12-01 |
| Completed | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization Neuroendocrine Tumor, Islet Cell Tumor | Phase 2 | 2006-11-01 |
| Completed | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Liposarcoma, Leiomyosarcoma, Fibrosarcoma | Phase 2 | 2006-11-01 |
| Completed | Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer Lung Cancer | Phase 2 | 2006-10-01 |
| Terminated | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (H Liver Cancer | Phase 2 | 2006-10-01 |
| Completed | The Human Papillomavirus (HPV) Transmission Pilot Study Human Papillomavirus Infection | — | 2006-10-01 |
| Terminated | A Phase I/II Study of Sunitinib and Dacarbazine Melanoma | Phase 1 / Phase 2 | 2006-09-01 |
| Completed | Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemothera Leukemia | Phase 2 | 2006-08-01 |
| Completed | Support for People Undergoing Chemotherapy Quality of Life, Cancer | N/A | 2006-08-01 |
| Terminated | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2006-07-01 |
| Terminated | Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma Glioblastoma, Gliosarcoma | Phase 2 | 2006-07-01 |
| Completed | Drug /Cue Interactions In Alcohol-Tobacco Comorbidity Nicotine Dependence | N/A | 2006-05-08 |
| Completed | External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma Soft Tissue Sarcoma | Phase 2 | 2006-05-01 |
| Terminated | Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation Acute Myeloid Leukemia (AML) | N/A | 2006-05-01 |
| Completed | Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess Cancer, Cancer Screening Patients, Patient Volunteers | — | 2006-03-01 |
| Completed | Dendritic Cell Vaccination During Lymphoid Reconstruction Intraocular Melanoma, Melanoma (Skin) | Phase 1 | 2006-02-01 |
| Terminated | Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodend Astrocytoma, Glioma, Oligodendroglioma | Phase 2 | 2006-02-01 |
| Completed | Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer Breast Cancer | Phase 2 | 2006-02-01 |
| Completed | Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexat Mucositis, Graft-versus-host Disease | N/A | 2005-09-01 |
| Terminated | A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2005-08-01 |
| Completed | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic | Phase 4 | 2005-08-01 |
| Terminated | Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. Esophageal Adenocarcinomas, Adenocarcinomas of the Gastroesophageal Junction | Phase 2 | 2005-07-01 |
| Completed | Natural History of HPV Infection in Men: The HIM Study Human Papillomavirus | — | 2005-06-14 |
| Completed | Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transpl Multiple Myeloma, Plasma Cell Leukemia | Phase 2 | 2005-06-01 |
| Terminated | Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma Malignant Melanoma | Phase 1 / Phase 2 | 2005-03-01 |
| Completed | Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer Colorectal Cancer | Phase 2 | 2004-12-01 |
| Terminated | Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates Lung Cancer | N/A | 2004-10-01 |
| Completed | Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander C Melanoma (Skin) | Phase 2 | 2004-10-01 |
| Completed | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer Kidney Cancer | Phase 2 | 2004-08-01 |
| Completed | Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumo Lymphoma | Phase 2 | 2004-07-01 |
| Completed | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma Malignant Melanoma | N/A | 2004-06-01 |
| Completed | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies Neoplasms, Advanced | Phase 1 | 2004-03-01 |
| Completed | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. Lung Cancer | Phase 2 | 2004-02-01 |
| Completed | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell L Carcinoma, Non-Small-Cell Lung | Phase 2 | 2004-02-01 |
| Terminated | Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) Adenocarcinoma, Colon Cancer | Phase 2 | 2003-10-01 |
| Completed | Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2003-07-01 |
| Completed | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Car Esophageal Cancer, Gastric Cancer | Phase 2 | 2003-07-01 |
| Terminated | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) Multiple Myeloma | Phase 3 | 2003-06-01 |
| Completed | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC Lung Cancer | Phase 2 | 2003-04-01 |
| Completed | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2003-04-01 |
| Terminated | Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy Breast Cancer | N/A | 2002-12-01 |
| Completed | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy Prostate Cancer | N/A | 2002-07-01 |
| Completed | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk Prostate Cancer | Phase 2 | 2002-02-01 |